+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

Focal Segmental Glomerulosclerosis Global Market Report 2025 - Product Thumbnail Image

Focal Segmental Glomerulosclerosis Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
From
Chronic Hepatitis B Market Report 2025 - Product Thumbnail Image

Chronic Hepatitis B Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Liver Disease Diagnostics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Liver Disease Diagnostics Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 190 Pages
  • Global
From
From
From
From
From
Renal Anemia Treatment - Global Strategic Business Report - Product Thumbnail Image

Renal Anemia Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 278 Pages
  • Global
From
Liver Disease Diagnostics - Global Strategic Business Report - Product Thumbnail Image

Liver Disease Diagnostics - Global Strategic Business Report

  • Report
  • November 2025
  • 380 Pages
  • Global
From
From
From
Complement 3 Glomerulopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Complement 3 Glomerulopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Autoimmune Hepatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Autoimmune Hepatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Autosomal Dominant Polycystic Kidney Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Autosomal Dominant Polycystic Kidney Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Primary Sclerosing Cholangitis - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Sclerosing Cholangitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Renal Tubular Acidosis (RTA) - Pipeline Insight, 2025 - Product Thumbnail Image

Renal Tubular Acidosis (RTA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
Hepatitis C Virus Infection- Pipeline Insight, 2025 - Product Thumbnail Image

Hepatitis C Virus Infection- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more